Get the Stockscreener App
1.10
1.79%
-0.02
After Hours:
1.11
0.01
+0.91%
Iridex Corp stock is traded at $1.10, with a volume of 75,644.
It is down -1.79% in the last 24 hours and down -2.65% over the past month.
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
See More
Previous Close:
$1.12
Open:
$1.12
24h Volume:
75,644
Relative Volume:
0.36
Market Cap:
$19.15M
Revenue:
$52.58M
Net Income/Loss:
$-3.28M
P/E Ratio:
-5.7084
EPS:
-0.1927
Net Cash Flow:
$-2.53M
1W Performance:
-2.65%
1M Performance:
-2.65%
6M Performance:
-4.35%
1Y Performance:
+6.80%
1-Day Range:
$1.10
$1.125
1-Week Range:
$1.10
$1.15
52-Week Range:
$0.8688
$1.6481
Iridex Corp Stock (IRIX) Company Profile
Name
Iridex Corp
Sector
Industry
Phone
(650) 940-4700
Address
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Compare IRIX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
1.10 | 19.15M | 52.58M | -3.28M | -2.53M | -0.1927 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-17 | Resumed | ROTH Capital | Buy |
| Dec-21-16 | Initiated | ROTH Capital | Buy |
| Jan-26-16 | Initiated | Singular Research | Buy |
| Jan-03-07 | Initiated | First Albany | Buy |
Iridex Corp Stock (IRIX) Latest News
Form 4 IRIDEX Corporation For: 8 July By Investing.com - Investing.com Nigeria
Novel Inspiration gains IRIDEX (IRIX) shares as quarterly note interest - Stock Titan
IRIDEX Corp updates retinal laser portfolio as ophthalmology demand evolves - ad-hoc-news.de
IRIDEX Corporation (IRIX) Slides Amid Light Trading, Key Support Levels in FocusArms Index - dars.gov.et
IRIX Q1 2026 Earnings: Loss Narrows Significantly as EPS Surprises to the UpsideEarnings Revision Upgrade - dars.gov.et
IRIDEX Corp (IRIX) Valuation: PE, PB & Fair Value Analysis - TradingKey
IRIDEX Corp (IRIX) Institutional Confidence - TradingKey
IRIDEX Corp (IRIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IRIDEX (IRIX) adjourns 2026 shareholder meeting, sets July 10 reconvene date - Stock Titan
IRIDEX Corp (IRIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IRIDEX Corp (IRIX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IRIDEX Corp (IRIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IRIDEX Corp (IRIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IRIDEX Corp (IRIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IRIDEX Corp (IRIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IRIDEX (IRIX) CFO has 2,691 shares withheld to pay taxes - Stock Titan
IRIDEX (IRIX) CEO surrenders 3,990 shares to cover tax obligations - Stock Titan
Insider Buying: Romeo Dizon Acquires Additional Shares of IRIDEX Corp (IRIX) - GuruFocus
Iridex CFO Romeo Dizon buys $1,110 in company stock - Investing.com UK
Iridex CFO Romeo Dizon buys $1,110 in company stock By Investing.com - Investing.com South Africa
IRIDEX (IRIX) CFO Romeo Dizon adds 975 common shares in open-market buy - Stock Titan
IRIX News | IRIDEX CORP (NASDAQ:IRIX) - ChartMill
Iridex CFO Romeo Dizon buys $1,909 in company stock By Investing.com - Investing.com Australia
Iridex CFO Romeo Dizon buys $1,909 in company stock - Investing.com
IRIDEX (IRIX) CFO Romeo Dizon adds 1,675 shares in open-market stock purchase - Stock Titan
Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference - The Manila Times
Iridex CFO Romeo Dizon buys $2,688 in company stock By Investing.com - Investing.com Australia
Iridex CFO Romeo Dizon buys $2,688 in company stock - Investing.com
IRIDEX (IRIX) CFO Romeo Dizon adds 2,400 shares in open-market buy - Stock Titan
Iridex CFO Dizon purchases $2,899 of common stock By Investing.com - Investing.com India
Iridex CFO Dizon purchases $2,899 of common stock - Investing.com UK
IRIDEX Corp (IRIX) CFO adds 2,521 shares in open-market stock purchase - Stock Titan
IRIDEX Corp stock (US4627191006): Laser eye-care specialist after recent earnings update - Ad-hoc-news.de
Iridex CFO Romeo Dizon buys $2,808 in company stock By Investing.com - Investing.com Nigeria
Iridex CFO Romeo Dizon buys $2,808 in company stock - Investing.com
CFO of IRIDEX (NASDAQ: IRIX) purchases 2,400 company shares - Stock Titan
Iridex CFO Romeo Dizon buys $5,004 in company stock By Investing.com - Investing.com Australia
IRIDEX (IRIX) CEO Patrick Mercer delivers shares to cover tax obligations - Stock Titan
Iridex Corp Stock (IRIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Iridex Corp Stock (IRIX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dizon Romeo R | Chief Financial Officer |
Jun 11 '26 |
Buy |
1.14 |
1,675 |
1,909 |
135,000 |
| Dizon Romeo R | Chief Financial Officer |
Jun 08 '26 |
Buy |
1.12 |
2,400 |
2,688 |
133,325 |
| Dizon Romeo R | Chief Financial Officer |
Jun 05 '26 |
Buy |
1.15 |
2,521 |
2,899 |
130,925 |
| Dizon Romeo R | Chief Financial Officer |
Jun 03 '26 |
Buy |
1.17 |
2,400 |
2,808 |
128,404 |
| Dizon Romeo R | Chief Financial Officer |
May 26 '26 |
Buy |
1.00 |
5,004 |
5,004 |
126,004 |
| Dizon Romeo R | Chief Financial Officer |
Mar 06 '26 |
Buy |
1.26 |
1,110 |
1,399 |
121,000 |
| Dizon Romeo R | Chief Financial Officer |
Feb 17 '26 |
Buy |
1.34 |
2,200 |
2,942 |
119,890 |
| Dizon Romeo R | Chief Financial Officer |
Feb 12 '26 |
Buy |
1.43 |
1,500 |
2,145 |
117,690 |
| Dizon Romeo R | Chief Financial Officer |
Feb 10 '26 |
Buy |
1.46 |
1,000 |
1,460 |
116,190 |
| Dizon Romeo R | Chief Financial Officer |
Feb 03 '26 |
Buy |
1.38 |
2,500 |
3,450 |
115,190 |
2.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):